STAAR 서지컬(STAA)는 NAS에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $20.82 (-1.98%), 시가총액 $1.63B, 52주 범위 $16.10 ~ $33.05.
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists.
STAAR 서지컬의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
STAAR 서지컬의 현재 주가는 $20.82 (-1.98%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
STAAR 서지컬의 시가총액은 약 $1.63B입니다.
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the…